losartan
Brand names: Cozaar
Losartan is a medicine that lowers blood pressure. It can also help prevent strokes in some people with high blood pressure and an enlarged heart.
Drug Pricing (NADAC)
Brand Price
$5.59/unit
Generic Price
$0.05/unit
Generic Savings
99%
Generic Available
Yes (24 manufacturers)
Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →
What it does
Losartan is used to treat high blood pressure in adults and children over 6 years old.
Common side effects
Dizziness, Upper respiratory infection, Nasal congestion
Key warnings
Losartan can harm your unborn baby, even causing death.
How It Works
Losartan blocks a substance in your body that tightens blood vessels. This helps blood vessels relax, which lowers blood pressure. It also helps the kidneys work better in people with diabetes.
How to Take It
Take losartan once a day, with or without food. The usual starting dose for adults is 50 mg. Your doctor may increase the dose up to 100 mg daily if needed. For children, the starting dose is based on weight. Follow your doctor's instructions carefully.
Pregnancy & Breastfeeding
Do not take losartan if you are pregnant. It can cause serious harm or death to the developing fetus. If you are breastfeeding, talk to your doctor about whether losartan is right for you.
Missed Dose
If you miss a dose, take it as soon as you remember. If it is close to your next dose, skip the missed dose and continue with your regular schedule.
Storage
Store losartan at room temperature (68°F to 77°F) and protect it from light.
Side Effects (from patient reports)
Based on 85,155 FDA adverse event reports.
FDA Adverse Event Report Analysis
Detailed analysis of 165,585 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2001–2025.
Total Reports
165,585
Death-Related Reports
12,034
Hospitalization Reports
48,929
Top Indication
Product Used For Unknown Indication
Gender Distribution
Age Distribution
Most Reported Adverse Reactions (FAERS)
| # | Reaction | Reports |
|---|---|---|
| 1 | FATIGUE | 11,852 |
| 2 | DIARRHOEA | 9,870 |
| 3 | NAUSEA | 9,207 |
| 4 | DRUG INEFFECTIVE | 9,195 |
| 5 | DYSPNOEA | 8,439 |
| 6 | DIZZINESS | 7,999 |
| 7 | HEADACHE | 7,815 |
| 8 | PAIN | 7,325 |
| 9 | OFF LABEL USE | 7,154 |
| 10 | ARTHRALGIA | 6,302 |
| 11 | MALAISE | 5,919 |
| 12 | ASTHENIA | 5,867 |
| 13 | COUGH | 5,353 |
| 14 | FALL | 5,234 |
| 15 | VOMITING | 5,173 |
Reactions in Death Reports
Reactions in Hospitalization Reports
Source: FDA FAERS (Adverse Event Reporting System) FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation
Serious Warnings
Losartan can harm your unborn baby, even causing death. If you are pregnant or plan to become pregnant, tell your doctor right away. Stop taking losartan as soon as you know you are pregnant.
Known Drug Interactions
7.4 Dual Blockade of the Renin-Angiotensin System (RAS) Dual blockade of the RAS with angiotensin receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, syncope, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy. Do not coadminister aliskiren with losartan potassium in patients with diabetes. Avoid use of aliskiren with losartan potassium in patients with renal impairment (GFR <60 mL/min).
Mechanism: Taking these two drugs together can over-block the system that controls blood pressure, potentially causing fainting or kidney failure.
What to do: You should not use these drugs together if you have diabetes or poor kidney function.
(7.1) • Lithium: Risk of lithium toxicity. 7.2 Lithium Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists. Monitor serum lithium levels during concomitant use.
Mechanism: Losartan can make it harder for your body to get rid of lithium. This can cause lithium to build up to dangerous levels in your blood.
What to do: Your doctor should monitor your lithium blood levels closely while you take these drugs together. Watch for signs of too much lithium, like tremors or feeling very thirsty.
Losartan : Fluconazole inhibits the metabolism of losartan to its active metabolite (E-31 74) which is responsible for most of the angiotensin II-receptor antagonism which occurs during treatment with losartan.
Mechanism: Fluconazole prevents losartan from changing into its active form that helps lower blood pressure. This can make the blood pressure medicine work less effectively.
What to do: Your doctor may need to monitor your blood pressure and adjust your treatment if it is not controlled.
7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.
Mechanism: There are no known significant interactions between these two medications.
What to do: You can continue taking both medications at your current doses.
The VA NEPHRON trial enrolled 1448 patients with type 2 diabetes, elevated urinary-albumin-to-creatinine ratio, and decreased estimated glomerular filtration rate (GFR 30 to 89.9 ml/min), randomized them to lisinopril or placebo on a background of losartan therapy and followed them for a median of 2.2 years. Patients receiving the combination of losartan and lisinopril did not obtain any additional benefit compared to monotherapy for the combined endpoint of decline in GFR, end state renal disease, or death, but experienced an increased incidence of hyperkalemia and acute kidney injury comp...
Mechanism: Combining these types of blood pressure medicines can increase the risk of kidney damage and high potassium levels.
What to do: Your doctor should monitor your kidney function and potassium levels closely if these drugs are used together.
Common Questions
Can I take losartan if I have diabetes?
Can I drink alcohol while taking losartan?
How long does it take for losartan to lower blood pressure?
Can I stop taking losartan if my blood pressure is normal?
Are there any foods I should avoid while taking losartan?
Can losartan cause weight gain?
Can losartan cause hair loss?
Is it safe to take losartan with other medications?
What should I do if I experience side effects from losartan?
Can children take Losartan?
What are the common side effects of losartan?
Does losartan interact with other medications?
What drug class is losartan?
Is there a generic version of losartan?
Is losartan safe during pregnancy?
Has losartan been recalled?
Active Recalls
CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.
Teva Pharmaceuticals USA
CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.
Teva Pharmaceuticals USA
CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level of 9.82 parts per million.
Torrent Pharma Inc.
CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.
Teva Pharmaceuticals USA
CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level of 0.96 parts per million.
AVKARE Inc.
CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level.
Torrent Pharma Inc.
CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level.
Torrent Pharma Inc.
CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level.
Torrent Pharma Inc.
CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) detected
Legacy Pharmaceutical Packaging LLC
CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) detected
Legacy Pharmaceutical Packaging LLC
CGMP Deviations; trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) detected in the active pharmaceutical ingredient
Camber Pharmaceuticals Inc
CGMP Deviations; trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) detected in the active pharmaceutical ingredient
Camber Pharmaceuticals Inc
CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level.
Torrent Pharma Inc.
CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level.
Torrent Pharma Inc.
CGMP Deviations; trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) detected in the active pharmaceutical ingredient
Camber Pharmaceuticals Inc
CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level.
Torrent Pharma Inc.
CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.
Torrent Pharma Inc.
CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.
Torrent Pharma Inc.
CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.
Sandoz, Inc
Related Medications in Angiotensin II Receptor Blocker (ARB)
Other drugs grouped near losartan — same-class peers and common alternatives.
acebutolol
Sectral
Acebutolol is a medicine that helps lower blood pressure and control irregular heartbeats.
Compare with losartan →
aliskiren
Tekturna
Tekturna is a medicine used to treat high blood pressure.
Compare with losartan →
amiloride
Midamor
Amiloride is a water pill that helps your body hold onto potassium.
Compare with losartan →
amlodipine
Norvasc
Amlodipine (Norvasc) is a drug that lowers blood pressure and treats chest pain.
Compare with losartan →
amlodipine/benazepril
Lotrel
Lotrel is a combination medicine that contains amlodipine and benazepril.
Compare with losartan →
Medication Guides
Understanding Drug Interactions
How CYP450 enzymes, inhibitors, and inducers affect your medications
Generic vs Brand Name Drugs
FDA requirements, cost savings, and when the difference matters
Narrow Therapeutic Index Drugs
Why some drugs demand precise dosing and monitoring
Common Drug Interactions
Dangerous medication combinations and how to protect yourself
Related Health & Safety Data
🩺 Find a Doctor
Search prescribers for Angiotensin II Receptor Blocker (ARB)
🏨 Hospital Quality
CMS hospital ratings, safety scores & patient outcomes
💊 Supplement Data
NIH DSLD — check supplement ingredients & label claims
🍽️ Food Safety Alerts
FDA recalls, inspections & outbreak investigations
⚠️ Product Recalls
FDA, CPSC & NHTSA recall search
💉 Procedure Costs
Medicare procedure pricing for 9,297 procedures
Save on losartan
Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.
Disclosure: This link may earn us a commission at no extra cost to you. See our terms.
What the FDA Data Shows for losartan
The FDA label for losartan (sold under brand names such as Cozaar) classifies it as a prescription-only medication in the Angiotensin II Receptor Blocker (ARB) class. Losartan is used to treat high blood pressure in adults and children over 6 years old. Official labeling lists 4 commonly reported side effects, including Dizziness, Upper respiratory infection, Nasal congestion.
Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 85,155 voluntary reports. The database also lists 10 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated major severity. NADAC pricing from CMS shows a generic unit cost of $0.05 versus $5.59 for the brand — a 99% generic savings.
Report counts do not establish causation — a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history (currently 19 recall records on file), and patent information further shape supply and switching decisions. This page summarizes public FDA data for educational purposes only and is not a substitute for professional medical advice — always consult a licensed healthcare provider before starting, stopping, or changing any medication.
Data Sources
Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).
FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. Always consult a healthcare professional before making medication decisions.
Last updated: October 22, 2025
Read our methodology — how this data is sourced, computed, and verified.
All federal data sources used on this page
- FDA Orange Book — approved drug products with therapeutic equivalence. accessdata.fda.gov/cder/ob
- FDA DailyMed — NIH-hosted drug labeling for FDA-approved meds. dailymed.nlm.nih.gov
- FDA Adverse Event Reporting System (FAERS) — post-marketing safety surveillance. fda.gov/drugs/faers
- NLM RxNorm — standardized clinical drug nomenclature. nlm.nih.gov/research/umls/rxnorm
- CMS Medicare Part B Drug Average Sales Price Files — federal drug pricing data. cms.gov/medicare/part-b-drugs/asp
- FDA Drug Shortages Database — current and resolved drug shortage tracking. accessdata.fda.gov/drugshortages